Lord, Abbett & Co
CDNA icon

Lord, Abbett & Co’s CareDx CDNA Stock Holding History

Lord, Abbett & Co’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-224,576
Closed -$4.39M – 542
2025
Q2 		$4.39M Sell
224,576
-288,973
-56% -$5.13M 0.01% 474
2025
Q1 		$9.12M Buy
513,549
+135,025
+36% +$2.91M 0.03% 388
2024
Q4 		$8.1M Buy
378,524
+30,305
+9% +$737K 0.03% 413
2024
Q3 		$10.9M Buy
+348,219
New +$8.66M 0.03% 395
2021
Q4 		– Sell
-1,073,263
Closed -$68M – 615
2021
Q3 		$68M Sell
1,073,263
-31,224
-3% -$2.38M 0.16% 194
2021
Q2 		$101M Sell
1,104,487
-4,644
-0.4% -$369K 0.24% 118
2021
Q1 		$75.5M Buy
1,109,131
+139,636
+14% +$10.8M 0.19% 170
2020
Q4 		$70.2M Buy
969,495
+867,563
+851% +$50.3M 0.19% 173
2020
Q3 		$3.87M Buy
+101,932
New +$3.44M 0.01% 587
2020
Q1 		– Sell
-802,587
Closed -$17.3M – 638
2019
Q4 		$17.3M Sell
802,587
-934,905
-54% -$21.4M 0.06% 421
2019
Q3 		$39.3M Sell
1,737,492
-104,868
-6% -$2.9M 0.13% 252
2019
Q2 		$66.3M Sell
1,842,360
-374,186
-17% -$12M 0.22% 152
2019
Q1 		$69.9M Buy
2,216,546
+723,396
+48% +$21.1M 0.23% 127
2018
Q4 		$37.5M Buy
1,493,150
+1,025,020
+219% +$26.3M 0.14% 235
2018
Q3 		$13.5M Buy
+468,130
New +$8.76M 0.04% 577

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Lord, Abbett & Co's CDNA Position: Q3 2025 in Review

Lord, Abbett & Co sold out of CareDx (CDNA) in Q3 2025, closing a stake of 224,576 shares — an estimated $4.39M sold.

Lord, Abbett & Co first reported a position in CDNA in Q3 2018 and held it in 15 quarters. The position peaked at $101M in Q2 2021. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.

  • Lord, Abbett & Co reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
  • Lord, Abbett & Co sold 224,576 CareDx shares in Q3 2025, an estimated $4.39M.
  • Lord, Abbett & Co first reported a position in CareDx in Q3 2018 and held it in 15 quarters.
  • Lord, Abbett & Co's CareDx position peaked at $101M in Q2 2021.
  • 187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.

Based on Lord, Abbett & Co's 13F filing for Q3 2025, filed 13 Nov 2025.